5-HT3 receptors

Pharmacochemistry Library

Volumn 27, Issue C, 1997, Pages 221-258

  Gozlan, H ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957038735     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80016-5     Document Type: Article

References (239)

1. Hoyer D., and Martin G.R. Behav Brain Res 73 (1996) 263-268
2. Gaddum J.H., and Picarelli Z.P. Br J Pharmacol 12 (1957) 323-328
3. Kilpatrick G.J., Bunce K.T., and Tyers M.B. Med Res Rev 10 (1990) 441-475
4. Costall B., Naylor R.J., and Tyers M.B. Pharmacol Ther 47 (1990) 181-202
5. Barnes J.M., Barnes N.M., and Cooper S.J. Neurosc Behav Rev 16 (1992) 107-113
6. Peters J.A., Malone H.M., and Lambert J.J. Trends Pharmacol Sci 13 (1992) 391-397
7. Zifa E., and Filion G. Pharmacol Rev 44 (1992) 401-458
8. 3 receptors (1992), Acad Press, London
9. Greenshaw A.J. Trends Pharmacol Sci 14 (1993) 265-270
10. Apud J.A. Neuropsychopharmacol 8 (1993) 117-130
11. Emerit M.B., Riad M., Fattaccini C.M., and Hamon M. Neurochem 60 (1993) 2059-2067
12. Richardson B.P., Engel G., Donatsch P., and Stadler P.A. Nature 316 (1985) 126-131
13. Van Wijngaarden I., Tulp M.T.M., and Soudijn W.T. Eur J Pharmacol Mol Pharmacol 188 (1990) 301-312
14. Fozard J.R. In: Saxena P.R., Wallis D.I., Wouters W., and Bevan P. (Eds). Cardiovascular pharmacology of 5-hydroxytryptamine (1990), Kluwer Academic Publishers, Dordrecht 101-115
15. Craig D.A., Eglen R.M., Walsch K.L.M., Perkins L.A., et al. Naunyn Schmiedeberg's Arch Pharmacol 342 (1990) 9-16
16. Ireland S.J., and Tyers M.B. Br J Pharmacol 90 (1987) 229-238
17. Kilpatrick G.J., Butler A., Burridge J., and Oxford A.W. Eur J Pharmacol 182 (1990) 193-197
18. Boess F.G., Sepulveda M.I., Lummis S.C.R., and Martin I.L. Neurochem Int 31 (1992) 561-564
19. Bachy A., Héaulme M., Giudice A., et al. Eur J Pharmacol 237 (1993) 299-309
20. Glennon R.A., Young R., and Dukat M. Pharmacol Biochem Behav 41 (1992) 361-364
21. Schmidt C.J., and Black C.K. Eur J Pharmacol 167 (1989) 309-310
22. Kean P.E., Bachy A., Giudice A., Michaud J.C., et al. Third IUPHAR Satellite meeting on Serotonin. Chicago, USA (1993) 82
23. Richardson B.P., and Buchheit K.M. In: Osborne N.N., and Hamon M. (Eds). Neuronal Serotonin (1988), John Wiley & Sons, Chichester 465-506
24. Ruat M., Traiffort E., Arrang J.-M., et al. Biochem Biophys Res Commun 193 (1993) 268-276
25. Shen Y., Monsma Jr. F.J., Metcalf M.A., Jose P.A., et al. Biol Chem 268 (1993) 18200-18204
26. Bockaert J., Fozard J.R., Dumuis A., and Clarke D.E. Trends Pharmacol Sci 13 (1992) 141-145
27. Rosen T., Seeger T.F., McLean S., et al. J Med Chem 33 (1993) 3020-3023
28. Rasmussen K., Stockton M.E., and Czachura J.R. Eur J Pharmacol 205 (1991) 113-116
29. 3 receptors (1992), Academic Press, London 59-88
30. Fozard J.R., Mobarok Ali A., and Newgrosh G. Eur J Pharmacol 59 (1979) 195-210
31. Fozard J.R., and Mobarok Ali A. Eur J Pharmacol 49 (1978) 109-112
32. Rosen T., Nagel A.A., Rizzi J.P., et al. J Med Chem 33 (1990) 2715-2720
33. Swain C.J., Baker R., Kneen C., et al. J Med Chem 35 (1991) 1019-1031
34. Swain C.J., Baker R., Kneen C., et al. J Med Chem 34 (1991) 140-151
35. Collin S., El Tayar N., Van de Waterbeemd H., et al. Eur J Med Chem 24 (1989) 163-169
36. King F.D., Dabbs S., Bermudez J., and Sanger G.J. J Med Chem 33 (1990) 2942-2944
37. Bradley G., Ward T.J., White J.C., Coleman J., et al. J Med Chem 35 (1992) 1515-1520
38. Hibert M.F., Hoffmann R., Miller R.C., and Carr A.A. J Med Chem 33 (1990) 1594-1600
39. Rizzi J.P., Nagel A.A., Rosen R., McLean S., et al. J Med Chem 33 (1990) 2721-2725
40. Evans S.M., Galdes A., and Gall M. Pharmacol Biochem Behav 40 (1991) 1033-1040
41. Kilpatrick G.J., Jones B.J., and Tyers M.B. Nature 330 (1987) 746-748
42. Kilpatrick G.J., Butler A., Hagen R.M., Jones B.J., et al. Naunyn Schmiederberg's Arch Pharmacol 342 (1990) 22-30
43. Wong E., Bonhaus D.W., Wu I., Stefanich E., et al. J Neurochem 60 (1993) 921-930
44. Gehlert D.R., Schober D.A., Gackenheimer S.L., Mais D.E., et al. Neurochem Int 23 (1993) 373-383
45. Nelson D.R., and Thomas D.R. Biochem Pharmacol 38 (1989) 1693-1695
46. Barnes J.M., Barnes N.M., Champaneria S., Costall B., et al. Neuropharmacol 29 (1990) 1037-1045
47. Wong D.T., Robertson D.W., and Reid L.R. Eur J Pharmacol 166 (1989) 107-110
48. Barnes N.M., Costall B., and Naylor R.J. J Pharm Pharmacol 40 (1988) 548-551
49. Watling K.J., Aspley S., Swain C.J., and Saunders J. Eur J Pharmacol 149 (1988) 397-398
50. Hoyer D., and Neijt H.C. Eur J Pharmacol 143 (1987) 291-292
51. Milburn C.M., and Peroutka S.J. J Neurochem 52 (1989) 1787-1792
52. Koscielniak T., Ponchant M., Laporte A.-M., et al. CR Acad Sci Paris 311 (1990) 231-237
53. Kidd E.J., Levy J.-C., Nielsen M., Hamon M., et al. Eur J Pharmacol Mol Pharmacol 247 (1993) 45-56
54. Schmidt A.W., Hurt S.T., and Peroutka S.J. Eur J Pharmacol 171 (1989) 141-143
55. Meyerson L.R., and Park H. Drug Dev Res 23 (1991) 27-33
56. 41P. Steward L.J., West K.E., Baker J., Lummis S.C.R., and Barnes N.M. 2nd Int. Symp on Serotonin. Huston (1992)
57. Sharif N.A., Wong E., Loury D.N., et al. Br J Pharmacol 102 (1991) 919-925
58. Barnes J.M., Barnes N.M., Costall B., Ironside J.W., et al. J Neurochem 53 (1989) 1787-1793
59. Kilpatrick G.J., Barnes N.M., Chen C.H.K., Costall B., et al. Neurochem Int 19 (1991) 389-396
60. Kilpatrick G.J., Jones B.J., and Tyers M.B. Eur J Pharmacol 159 (1989) 157-164
61. Butler A., Elswood C.J., Burridge J., et al. Br J Pharmacol 101 (1990) 591-598
62. Richardson B.P., and Engel G. Trends Neurosci 9 (1986) 424-428
63. Newberry N.R., Cheshire S.H., and Gilbert M.J. Br J Pharmacol 102 (1991) 615-620
64. Bolaños F.J., Schechter L.E., Miquel M.C., et al. Biochem Pharmacol 40 (1990) 1541-1550
65. Waeber C., Dixon K., Hoyer D., and Palacios J.M. Eur J Pharmacol 151 (1988) 351-352
66. Perry D.C. Eur J Pharmacol 187 (1990) 75-85
67. Barnes J.M., Barnes N.M., Costall B., et al. Br J Pharmacol 105 (1992) 500-504
68. Barnes J.M., and Barnes N.M. Biochem Pharmacol 45 (1993) 2155-2158
69. 32P. Gozlan H., Kidd E., Gérard C., Emerit M.B., et al. 2nd Int Symp Serotonin. Houston (1992)
70. Neijt H.C., Te Duits I.J., and Vijverberg H.P.M. Neuropharmacol 27 (1988) 301-307
71. Sancilio L.F., Pinkus L.M., Jackson C.B., and Munson Jr. H.R. Eur J Pharmacol 181 (1990) 303-306
72. Barnes J.M., Barnes N.M., Costall B., et al. Biochem Behav 37 (1990) 717-727
73. Bradley P.B., Engel G., Peniuk W., et al. Neuropharmacol 6 (1986) 563-575
74. Fozard J.R. Peripheral actions of 5-hydroxytryptamine (1989), Oxford Univ Press, Oxford
75. Pinkus L.M., Sarbin N.S., Gordon J.C., and Munson Jr. H.R. Eur J Pharmacol 179 (1990) 231-235
76. Hoyer D., Waeber C., Korf A., Neijt H., et al. Naunyn Schmiedeberg's Arch Pharmacol 340 (1989) 396-402
77. Kilpatrick G.J., Jones B.J., and Tyers M.B. Neurosci Lettr 94 (1988) 156-159
78. Hamon M., Gallissot M.C., Menard F., Gozlan H., et al. Eur J Pharmacol 164 (1989) 315-322
79. Reynolds D.J.M., Leslie R.A., Grahame-Smith D.G., and Harvey J.M. Eur J Pharmacol 174 (1989) 127-130
80. Waeber C., Hoyer D., and Palacios J.M. Neurosci 31 (1989) 393-400
81. Pratt G.D., and Bowery N.G. Neuropharmacol 28 (1989) 1367-1376
82. Waeber C., Pinkus L.M., and Palacios J.M. Eur J Pharmacol 181 (1990) 283-287
83. Barnes J.M., Barnes N.M., Costall B., Naylor I.L., et al. Naunyn Schmiedeberg's Arch Pharmacol 342 (1990) 17-21
84. Leslie R.A., Reynolds D.J.M., Andrews P.L.R., Grahame-Smith D.G., et al. Neurosci 38 (1990) 667-673
85. Reynolds D.J.M., Leslie R.A., Grahame-Smith D.G., and Harvey J.M. Neurochem Int 18 (1991) 69-73
86. Gehlert D.R., Gackenheimer S.L., Wong D.T., and Robertson D.W. Brain Res 553 (1991) 149-154
87. Laporte A.M., Koscielniak T., Ponchant M., Vergé D., et al. Synapse 10 (1992) 271-281
88. Palacios J.M., Waeber C., Mengod G., and Hoyer D. Neurochem Int 18 (1991) 17-25
89. Merahi N., Orer H.S., Laporte A.-M., Gozlan H., et al. Neurosci 1 (1992) 91-100
90. Miller A.D., and Nonaka S. J Pharmacol Exp Ther 260 (1992) 509-517
91. Hoyer D., Gozlan H., Bolaños F., Schechter L.E., et al. Eur J Pharmacol 171 (1989) 137-139
92. Reiser G., and Hamprecht B. Brain Res 479 (1989) 40-48
93. Derkach V., Surprenant A., and North R.A. Nature 339 (1989) 706-709
94. Yakel J.L., and Jackson M.B. Neuron 1 (1988) 615-621
95. Yang J. J Gen Physiol 96 (1990) 1177-1198
96. Yang J., Mathei A., and Hille B. J Physiol (Lond) 448 (1992) 237-256
97. Yakel J.L., Shao X.M., and Jackson M.B.T. Brain Res 533 (1990) 46-52
98. Peters J.A., Hales T.G., and Lambert J.J. Eur J Pharmacol 151 (1988) 491-495
99. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., et al. Science 254 (1991) 432-437
100. Shao X.M., Yakel J.L., and Jackson M.B. J Neurophysiol 65 (1991) 630-638
101. Hope A.G., Downie D.L., Sutherland L., Lambert J.J., et al. Eur J Pharmacol Mol Pharmacol 245 (1993) 187-192
102. Yakel J.L., Lagrutta A., Adelman J.P., and North R.A. Proc Natl Acad Sci USA 90 (1993) 5030
103. Miquel M.-C., Emerit M.B., Gozlan H., and Hamon M. Biochem Pharmacol 42 (1991) 1453-1461
104. Gordon J.C., Sarbin N.S., Barefoot D.S., and Pinkus L.M. Eur J Pharmacol Mol Pharmacol 188 (1990) 313-319
105. McKernan R.M., Biggs C.S., Gillard N., Quirk K., et al. Biochem J 269 (1990) 623-628
106. McKernan R.M., Gillard N.P., Quirk K., et al. J Biol Chem 265 (1990) 13572-13577
107. Miller K., Weisberg E., Fletcher P.W., and Teitler M. Synapse 11 (1992) 58-66
108. Boess F.G., Lummis S.C.R., and Martin I.L. J Neurochem 59 (1992) 1692-1701
109. Lummis S.C.R., and Martin I.L. Mol Pharmacol 41 (1992) 18-23
110. Gozlan H., Schechter L.E., Bolaños F., et al. Eur J Pharmacol 172 (1989) 497-500
111. Miquel M.-C., Emerit M.B., Bolaños F.J., Schechter L.E., et al. J Neurochem 55 (1990) 1526-1536
112. Lummis S.C.R., Nielsen M., Kilpatrick G.J., and Martin I.L. Eur J Pharmacol Mol Pharmacol 189 (1990) 229-232
113. Changeux J.-P., Devillers-Thiéry A., Galzi J.-L., and Bertrand D. Trends Pharmacol Sci 13 (1992) 299-301
114. Vandenberg R.J., Handford C.A., and Schofield P.R. Neuron 9 (1992) 491-496
115. Hibert M.F., Trumpp-Kalmeyer S., Bruinvels A., and Hoflack J. Mol Pharmacol 40 (1991) 8-15
116. Revah F., Bertrand D., Galzi J.-L., et al. Nature 353 (1991) 846-849
117. Kilpatrick G.J., and Tyers M.B. Biochem Soc Trans 20 (1992) 118-121
118. Hartig P.R., Branchek T.A., and Weinshank R.L. Trends Pharmacol Sci 13 (1992) 152-159
119. Metcalf M.A., McGuffin R.W., and Hamblin M.W. Biochem Pharmacol 44 (1992) 1917-1920
120. Oksenberg D., Marsters S.A., O'Dowd B.F., et al. Nature 360 (1992) 161-163
121. Galzi J.-L., Devillers-Thiéry A., Hussy N., Bertrand S., et al. Nature 359 (1992) 500-505
122. Bertrand D., Galzi J.L., Devillers-Thiéry A., Bertrand S., et al. Proc Natl Acad Sci, USA 90 (1993) 6971-6975
123. Blier P., and Bouchard C. Br J Pharmacol 108 (1993) 13-22
124. Glaum S.R., and Anderson E.G. Eur J Pharmacol 156 (1988) 287-290
125. Paudice P., and Raiteri M. Br J Pharmacol 103 (1991) 1790-1794
126. Tecott L.H., Maricq A.V., and Julius D. Proc Natl Acad Sci, USA 90 (1993) 1430-1434
127. Feuerstein T.J., and Hertting G. Naunyn Schmiedeberg's Arch Pharmacol 22 (1986) 191-197
128. Blandina P., Goldfarb J., Walcott J., and Green J.P. J Pharmacol Exp Ther 256 (1991) 341-347
129. Martin P., Gozlan H., and Puech A.J. Eur J Pharmacol 212 (1992) 73-78
130. Barnes J.M., Barnes N.M., Costall B., Naylor R.J., et al. Nature 338 (1989) 762-763
131. Bianchi C., Siniscalchi A., and Beani L. Neuropharmacology 25 (1986) 1043-1049
132. Bianchi C., Siniscalchi A., and Beani L. Br J Pharmacol 101 (1990) 448-452
133. Maura G., Andrioli G.C., Cavazzani P., and Raiteri M. J Neurochem 58 (1992) 2334-2337
134. Johnson R.M., Inouye G.T., Eglen E., and Wong E. Naunyn Schmiedeberg's Arch Pharmacol 347 (1993) 241-247
135. Consolo S., Bertorelli R., Russi G., Zambelli M., et al. J Neurochem 62 (1994) 2254-2261
136. Martin K.F., Hannon S., Philips I., and Heal D.J. Br J Pharmacol 106 (1992) 139-142
137. Barnes N.M., Cheng C.H.K., Costall B., Ge J., et al. Br J Pharmacol 107 (1992) 233-239
138. Williams G.M., Smith D.L., and Smith D.J. Neuropharmacol 31 (1992) 725-733
139. Kidd E.J., Laporte A.-M., Langlois X., et al. Brain Res 612 (1993) 289-298
140. Koulu M., Sjöholm B., Lappalainen J., and Virtanen R. Eur J Pharmacol 169 (1989) 321-324
141. Koulu M., Lappalainen J., Hietala J., and Sjöholm B. Psychopharmacol 101 (1990) 168-171
142. Imperato A., Puglisi-Allegra S., Zocchi A., Scrocco M.G., et al. Eur J Pharmacol 175 (1990) 211-214
143. Hagan R.M., Butler A., Hill J.M., Jordan C.G., et al. Eur J Pharmacol 138 (1987) 303-305
144. Carboni E., Acquas E., Leone P., Perezzani L., et al. Eur J Pharmacol 151 (1987) 159
145. Carboni E., Acquas E., Frau R., and DiChiara G. Eur J Pharmacol 164 (1989) 515-519
146. Carboni E., Acquas E., Leone P., and DiChiara G. Psychopharmacol 97 (1989) 175-178
147. Jiang L.H., Ashby C.R., Kasser R.J., and Wang R.Y. Brain Res 513 (1990) 156-160
148. Parsons L.H., and Justice Jr. J.B. Brain Res 606 (1993) 195-199
149. Chen J., Van Praag H.M., and Gardner E.L. Brain Res 543 (1991) 354-357
150. Jacocks H.M., and Cox B.M. J Pharmacol Exp Ther 262 (1992) 356-364
151. Harro J., Vasar E., and Bradwejn T. Trends Pharmacol Sci 14 (1993) 244-249
152. Woodruff G.N., and Hughes J. Ann Rev Pharmacol Toxicol 31 (1991) 469-501
153. Raiteri M., Paudice P., and Vallebuona F. Naunyn Schmiedeberg's Arch Pharmacol 347 (1993) 111-114
154. Blandina P., Goldfarb J., Carddock-Royal B., and Green J.P. J Pharmacol Exp Ther 251 (1989) 803-809
155. Blandina P., Goldfarb J., and Green J.P. Eur J Pharmacol 155 (1988) 349-350
156. Yi S.J., Gifford A.N., and Johnson K.M. Eur J Pharmacol 199 (1991) 185-189
157. Costall B., Domeney A.M., Naylor R.J., and Tyers M.B. Br J Pharmacol 92 (1987) 881-890
158. 141P. Van der Hoek G.A., and Cooper S.J. Br J Pharmacol 100 (1990)
159. Sorensen S.M., Humphreys T.M., and Palfreyman M.G. Eur J Pharmacol 163 (1989) 115-118
160. Palfreyman M.G., Schmidt C.J., Sorensen S.M., et al. Psychopharmacol 112 (1993) S60-S67
161. Ashby Jr. C.R., Jiang L.H., and Wang R. Eur J Pharmacol 175 (1990) 347-350
162. Wang RY, Ashby CR, Minabe Y. In: Serotonin 1991; Birmingham 1991; P74.
163. Prisco S., Pessia M., Ceci A., Borsini F., et al. Eur J Pharmacol 214 (1992) 13-19
164. Abbott A. Trends Pharmacol Sci 11 (1990) 49-51
165. Chen J., Paredes W., Van Praag H.M., Lowinson J.H., et al. Synapse 10 (1992) 264-266
166. Hagan R.M., Kilpatrick G.J., and Tyers M.B. Psychopharmacol 112 (1993) S68-S75
167. Bill D.J., Fletcher A., Glenn B.D., and Knight M. Eur J Pharmacol 218 (1992) 327-334
168. Costall B., Domeney A.M., Kelly M.E., et al. Eur J Pharmacol 234 (1993) 91-99
169. Domeney A.M., Costall B., Gerrard P.A., Jones D.N.C., et al. Pharmacol Biochem Behav 38 (1991) 169-175
170. Carey G.J., Costall B., Domeney A.M., et al. Pharmacol Biochem Behav 42 (1992) 75-83
171. Alhaider A.A., Lek S.Z., and Wilcox G.L. J Neurosci 11 (1991) 1881-1888
172. Aapro M.S. Drugs 42 (1991) 551-568
173. Hesketh P.J., and Gandara D.R. J Natl Cancer Inst 83 (1991) 613-620
174. Costall B., Domeney A.M., Gerrard P.A., Kelly M.E., et al. J Pharm Pharmacol 40 (1988) 302-305
175. Barnes N.M., Cheng C.H.K., Costall B., Ge J., et al. Eur J Pharmacol 218 (1992) 91-100
176. Young R., and Johnson D.N. Eur J Pharmacol 201 (1991) 151-155
177. File S.E., and Andrews N. Eur J Pharmacol 237 (1993) 127-130
178. Blackburn T.P., Baxter G.S., Kennett G.A., et al. Psychopharmacol 110 (1993) 257-264
179. Costall B., Kelly M.E., Naylor R.J., and Tomkins D.M. Br J Pharmacol 96 (1989) 325-332
180. Sugita A., Shen K.Z., and North R.A. Neuron 8 (1992) 199-203
181. Lecrubier Y., Puech A.J., Bailey P.E., and Lataste X. Psychopharmacol 112 (1993) 129-133
182. Lader M.H. Satel Symp of 5th World Congr of Biol Psych. Florence (1991) 17-19
183. McBain S.L., Dineen M., Weller M., et al. Schizophr Res 6 (1992) 112
184. Newcomer J.W., Faustman W.O., Zipursky R.B., and Czernansky J.G. Arch Gen Psych 49 (1992) 751-752
185. Sellers E.M., Higgins G.A., and Sobell M.B. Trends Pharmac Sci 13 (1992) 69-75
186. Barnes J.M., Costall B., Coughlan J., et al. Pharmacol Biochem Behav 35 (1990) 955-962
187. Chigh Y., Saha N., Sankaranaraynan A., and Sharma P.L. Eur J Pharmacol 203 (1991) 121-123
188. Jäkälä P., Sirvö J., and Riekkinen P.J. Gen Pharmacol 24 (1993) 675-679
189. Crook T.H., and Lakin M. Satel Symp of 5th World Congre of Biol Psych. Florence (1991) 21-23
190. Hall S.T., and Ceuppens P.R. Psychopharmacol 104 (1991) 315-322
191. Fozard J.R. In: Bevan J.A. (Ed). Proc 5th Int Symp on Vasc Neuroeff Mech (1985), Elsevier, Amsterdam 321-328
192. Saria A., Javorsky F., Humpel C., and Gamse R. Ann NY Acad Sci 632 (1991) 464-465
193. Tramontana M., Guiliani S., Del Bianco E., et al. Br J Pharmacol 108 (1993) 431-435
194. Loisy C., Beorchia S., Centonze V., Fozard J.R., et al. Cephalagia 5 (1985) 79-82
195. Couturier E., Hering R., Foster C.A., and Steiner T.J. Headache 31 (1991) 296-297
196. Rowat B.M.T., Merrill C.F., Davies A., and South V. Cephalagia 11 (1991) 207-213
197. Angel I., Schoemaker H., Prouteau M., Garreau M., et al. Eur J Pharmacol 232 (1993) 139-145
198. Gorcs T.J., Liposit Z., Palay S.F.L., and Chan-Palay V. Proc Natl Acad Sci 82 (1985) 7449-7452
199. Bhandari P., Bingham S., and Andrews P.L.R. Neuropharmacol 31 (1992) 735-742
200. Smith W.L., Callaham E.M., and Alphin R.S. J Pharm Pharmacol 40 (1988) 142-143
201. Higgins G.A., Kilpatrick G.J., Bunce K.T., Jones B.J., et al. Br J Phamracol 97 (1989) 247-255
202. Alexander E., Siddon R.L., and Loeffler J.S. Surg Neurol 32 (1989) 40-44
203. Monkovic I., and Gylys J.A. Prog Med Chem 27 (1990) 297-323
204. Dubois A., Fiala N., Boward C.A., and Bogo V. Radiat Res 115 (1988) 595-604
205. Andrews P.L.R., and Hawthorn J. Neuropharmacol 26 (1987) 1367-1370
206. Hawthorn J., Ostler K.J., and Andrews P.L.R.Q. J Exper Physiol 73 (1988) 7-21
207. Reiser G. Eur J Biochem 189 (1990) 547-552
208. Edwards E., Ashby C.R., and Wang R.Y. Brain Res 617 (1993) 113-119
209. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., et al. Pharmacol Rev 46 (1994) 157-203
210. Boess F.G., and Martin I.L. Neuropharmacol 33 (1994) 275-317
211. King F.D. In: King F.D., Jones B.J., and Sanger G.J. (Eds). 5-Hydroxytryptamine-3-receptor antagonists (1994), CRC, Boca Raton FLA 1-44
212. Jackson M.B., and Yakel J.L. Ann Rev Physiol 57 (1995) 447-468
213. Villalon C.M., Terron J.A., Raminez-San-Juan E., and Saxena P.R. Arch Med Res 26 (1995) 331-344
214. Rault S., Lancelot J.C., Prunier H., Robba M., et al. J Med Chem 39 (1996) 2068-2080
215. Clark R.D., Muchowski J.M., Weinhardt K.K., Dillon M.P., et al. Bioorg Med Chem Lettr 16 (1995) 1853-1856
216. Gerald C., Adham N., Kao H.T., Olsen M.A., et al. EMBO J 14 (1995) 2806-2815
217. Laguerre M., Dubost J.P., Kummer E., and Carpy A. Drug Design Disc 11 (1994) 205-222
218. Langlois M., Soulier J.L., Rampillon V., Gallais C., et al. Eur J Med Chem 29 (1994) 925-940
219. Ohta M., Suzuki T., Ohmori J., Koide T., et al. Chem Pharm Bull 44 (1996) 1000-1008
220. Kato M., Nishino S., Ito K., Yamakuni H., et al. Chem Pharm Bull 43 (1995) 1358-1363
221. Anzini M., Cappelli A., Vomero S., Giorgi G., et al. J Med Chem 38 (1995) 2692-2704
222. López-Rodrigues M.L., Morcillo M.J., Benhamú B., and Riaguas M.D. Bioorg Med Chem Lett 6 (1996) 1195-1198
223. Akuzawa S., Miyata K., and Fukutomi H. Eur J Pharmac 281 (1995) 37-42
224. Akuzawa S., Miyake A., Miyata K., and Fukutomi H. Eur J Pharmac 296 (1996) 227-230
225. Bonhaus D.W., Stefanich E., Loury D.N., Hsu S.A., et al. J Neurochem 65 (1995) 104-110
226. Werner P., Kawashima E., Reid J., Hussy N., et al. Mol Brain Res 26 (1994) 233-241
227. Downie D.L., Hope A.G., Lambert J.J., Peters J.A., et al. Neuropharmac 33 (1994) 472-483
228. Boess F.G., Beroukim R., and Martin I.L. J Neurochem 64 (1995) 1401-1405
229. Isenberg K.E., Ukhun I.A., Golstad S.G., Jafri S., et al. Neuro-Report 5 (1993) 121-124
230. Belelli D., Balharek J.M., Hope A.G., Peters J.A., et al. Mol Pharmac 48 (1995) 1054-1062
231. Miyake A., Mochizuki S., Takemoto Y., and Akuzawa S. Mol Pharm 48 (1995) 407-416
232. Hope A.G., Peters J.A., Brown A.M., Lambert J.J., et al. Brit J Pharmac 118 (1996) 1237-1245
233. Peters J.A., Lambert J.J., and Malone H.M. In: King F.D., Jones B.J., and Sanger G.J. (Eds). 5-Hydroxytryptamine-3 receptor antagonists (1994), CRC, Boca Raton FLA 115-153
234. Perren M.J., Roger H., Mason G.S., Bull D.R., et al. Naunyn Schiedeberg's Arch Pharmac 351 (1995) 221-228
235. Bentley K.R., and Barnes N.M. CNS Drugs 3 (1995) 363-392
236. Roca J., Artaiz I., and Del Rio J. Exp Opin Invest Drugs 4 (1995) 333-342
237. Sorbe B. Exp Opin Invest Drugs 5 (1996) 389-407
238. Wilde M.I., and Markham A. Drugs 52 (1996) 773-794
239. Poncelet M., Pério A., Simiand J., Gout G., et al. J Neural Transm 102 (1995) 83-90